Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Online-Ressource
    Online-Ressource
    S. Karger AG ; 2006
    In:  International Archives of Allergy and Immunology Vol. 140, No. 4 ( 2006), p. 315-320
    In: International Archives of Allergy and Immunology, S. Karger AG, Vol. 140, No. 4 ( 2006), p. 315-320
    Kurzfassung: 〈 i 〉 Background: 〈 /i 〉 Desloratadine is an H 〈 sub 〉 1 〈 /sub 〉 -histamine antagonist which possesses additional anti-inflammatory properties through inhibition of leukocyte activation and reduction of ICAM-1 expression on mucosal epithelial cells. So far no studies have addressed the potential anti-inflammatory activities of desloratadine and loratadine on skin keratinocytes. 〈 i 〉 Objective: 〈 /i 〉 In this study the capacity of desloratadine and loratadine to counteract human keratinocyte activation by interferon-γ (IFN-γ) was analyzed. In particular, the chemokine release of kerationcytes and the crosstalk between keratinocytes and lymphocytes were examined. 〈 i 〉 Method: 〈 /i 〉 Keratinocyte cultures established from normal skin of healthy donors were activated by IFN-γ in the absence or presence of desloratadine and loratadine, and tested for the release of CCL5/RANTES, CXCL8/IL-8, CCL17/TARC and CXCL10/IP-10. Furthermore the supernatants of differentially stimulated keratinocytes were used for migration studies of human neutrophils, eosinophils and polarized Th1/Th2 clones. 〈 i 〉 Results: 〈 /i 〉 Desloratadine and loratadine inhibited the constitutive and IFN-γ-induced release of CCL5, CXCL8 and CXCL10 from keratinocytes, while the low release of CCL17 remained unchanged. Furthermore the crosstalk between lymphocytes and keratinocytes was blocked as shown by a reduced capacity of desloratadine/loratadine-stimulated keratinocytes to attract human neutrophils, eosinophils and T cells. 〈 i 〉 Conclusions: 〈 /i 〉 The results indicate that desloratadine has the capacity to block the IFN-γ-induced activation of keratinocytes, and that it can thus exert important regulatory effects on cell-mediated immune responses in the skin. The rather high doses required for these effects argue for a topical application when trying to use desloratadine in epidermal inflammatory conditions.
    Materialart: Online-Ressource
    ISSN: 1018-2438 , 1423-0097
    RVK:
    Sprache: Englisch
    Verlag: S. Karger AG
    Publikationsdatum: 2006
    ZDB Id: 1482722-0
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz